A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Assessment and reporting of safety outcomes in clinical trials of cannabinoids for chronic pain: Protocol for a Systematic Review (Preprint)
[post]
2018
unpublished
BACKGROUND Chronic pain affects a significant proportion of the population and presents a major challenge to clinicians and pain specialists. Despite availability of pharmacologic treatment options such as opioids, chronic pain persists in patients, perhaps because of a lack of analgesic efficacy or poor tolerability due to adverse effects. Cannabinoids present an alternative option; however, it is unclear whether a clear profile of cannabinoid associated adverse events (AE) has been accurately
doi:10.2196/preprints.11637
fatcat:my57kr2o6jhjrfu7yesb4iv7fq